About | Free Trial

Last Update

2016-07-28T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong David Kleinman?

Dr. David Kleinman M.

Chief Executive Officer

Eyeon Therapeutics , Inc.

Eyeon Therapeutics , Inc.

Background Information

Employment History

Associate Professor of Ophthalmology (Part Time)

Flaum Eye Institute at the University of Rochester

Chief of Ophthalmology

Denver Health

Chief Medical Officer

ONL Therapeutics Inc

Education

BA

Brown University

Dean's Scholar

Simon School of Business

M.B.A.

M.D.

The University of Rochester Eye Institute

M.D.

University of Rochester Eye Institute - Donald Grover

M.D. with honors

University of Colorado School of Medicine

MBA

Simon School of Business

medical degree with honors

University of Colorado School of Medicine

Web References (91 Total References)


Eyeon Therapeutics Out-Licenses Proprietary OTC Dry Eye Product

www.prnewswire.com [cached]

David Kleinman, MD, CEO of Eyeon Therapeutics commented, "We are grateful to Particle Sciences for their support in helping us develop and advance this important new technology designed to provide a better treatment opportunity for dry eye patients, and we are delighted to have found an excellent commercial organization to bring this technology to patients with dry eye disease in North America.


David Kleinman, M.D., ...

www.lumetrics.com [cached]

David Kleinman, M.D., president of Eyeon Therapeutics, and a retinal specialist on FEI's faculty, has been actively involved in moving this promising technology forward.


Management – ONL Therapeutics

www.onltherapeutics.com [cached]

David M. Kleinman, M.D., M.B.A., Chief Medical Officer

Dr. Kleinman is a board-certified ophthalmologist with fellowship training in vitreoretinal surgery and more than ten years experience in venture creation and ophthalmic drug and device development. He currently serves as a part-time associated professor ophthalmology at the Flaum Eye Institute at the University of Rochester, where he specializes in the medical and surgical care of patients with retinal disease. David is the former chief of ophthalmology at Denver Health Medical Center, where he also served as an assistant professor of ophthalmology at the Rocky Mountain Lions Eye Institute.
In 2003, he helped found MacuSight, a venture capital backed retinal drug development company, where served as consulting medical director. In his role with MacuSight, David assisted in guiding the company through Series A financing, pre-clinical studies, initial investigational new drug (IND) submission, and Phase I/II clinical development. MacuSight's assets were acquired by Santen in 2010. He holds a bachelor's degree from Brown University, an MBA from the Simon School of Business, and an M.D. with honors from the University of Colorado School of Medicine.


David Kleinman, Associate ...

ois.net [cached]

David Kleinman, Associate Professor of Ophthalmology - Flaum Eye Institute


David M. Kleinman, M.D., ...

www.onltherapeutics.com [cached]

David M. Kleinman, M.D., M.B.A., Chief Medical Officer

Dr. Kleinman is a board-certified ophthalmologist with fellowship training in vitreoretinal surgery and more than ten years experience in venture creation and ophthalmic drug and device development. He currently serves as a part-time associated professor ophthalmology at the Flaum Eye Institute at the University of Rochester, where he specializes in the medical and surgical care of patients with retinal disease. David is the former chief of ophthalmology at Denver Health Medical Center, where he also served as an assistant professor of ophthalmology at the Rocky Mountain Lions Eye Institute.
In 2003, he helped found MacuSight, a venture capital backed retinal drug development company, where served as consulting medical director. In his role with MacuSight, David assisted in guiding the company through Series A financing, pre-clinical studies, initial investigational new drug (IND) submission, and Phase I/II clinical development. MacuSight's assets were acquired by Santen in 2010. He holds a bachelor's degree from Brown University, an MBA from the Simon School of Business, and an M.D. with honors from the University of Colorado School of Medicine.

Similar Profiles

Other People with this Name

Other people with the name Kleinman

Robert Kleinman
Arts Horizons Inc

Jason Kleinman
The Hearst Corporation

Victoria Kleinman
Telecom Brokerage , Inc.

Ellen Kleinman
El Castillo

Elly Kleinman
Ohel

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory